IMatinib Para-diaMinoMethylbenzene manufacturers
|
| | IMatinib Para-diaMinoMethylbenzene Basic information |
| Product Name: | IMatinib Para-diaMinoMethylbenzene | | Synonyms: | IMatinib Para-diaMinoMethylbenzene;Imatinib Impurity H;4-[(4-Methyl-1-piperazinyl)methyl]-N-[3-methyl-4-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide;Imatinib impuritiesD;IMatinib Para-diaMinoMethylbenzene USP/EP/BP;Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[3-methyl-4-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-;Imatinib Para PPA Imp;Imatinib para-PPA Impurity | | CAS: | 1026753-54-7 | | MF: | C29H31N7O | | MW: | 493.6 | | EINECS: | | | Product Categories: | | | Mol File: | 1026753-54-7.mol |  |
| | IMatinib Para-diaMinoMethylbenzene Chemical Properties |
| Melting point | >115°C (dec.) | | density | 1?+-.0.06 g/cm3(Predicted) | | storage temp. | Refrigerator | | solubility | Chloroform (Slightly), DMSO (Sparingly), Methanol (Slightly) | | form | Solid | | pka | 13.17±0.70(Predicted) | | color | Off-White to Yellow |
| | IMatinib Para-diaMinoMethylbenzene Usage And Synthesis |
| Uses | Imatinib para-Diaminomethylbenzene is an impurity of Imatinib, a tyrosine kinase inhibitor. It is a COVID19-related research product. |
| | IMatinib Para-diaMinoMethylbenzene Preparation Products And Raw materials |
|